Our investment strategy is focused on the specific areas of pain, depression and mental illness. By investing in pioneering techniques such as micro-dosing using organic compounds and synthetic molecules, we are focussing on ground breaking research with the aim of providing superior wellness benefits with less side effects, better for people and the planet.
We understand that addressing perceptions and being part of the education process into these new substances and their application is essential in bringing the products from idea to development to market. The requirement for credible research, peer reviewed studies, trials and patenting running along with legislative and government approval is an area we specialize in.